Back to the main directory
Press Release
- Bitfarms Schedules Second Quarter 2025 Conference Call on August 12, 2025 by GlobeNewsWire
- Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025 by GlobeNewsWire
- EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration by GlobeNewsWire
- Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease by GlobeNewsWire
- Archrock Announces Timing for Second Quarter 2025 Results by GlobeNewsWire
- Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 by GlobeNewsWire
- Oroco Receives Approval for Whittle Share Payment by GlobeNewsWire
- CECO Environmental Reports Second Quarter 2025 Results by GlobeNewsWire
- Agora Showcases Conversational AI Solutions at the World Artificial Intelligence Conference by GlobeNewsWire
- uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress by GlobeNewsWire
- Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution by GlobeNewsWire
- Dragonfly Energy Announces Second Quarter 2025 Select Preliminary Results Above Guidance by GlobeNewsWire
- Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease by GlobeNewsWire
- Brixton Metals Drills 16m of 3.4 g/t Gold, 96 g/t Silver, 0.59% Copper, 0.12% Antimony at the Glenfiddich Zone, Camp Creek Corridor by GlobeNewsWire
- BriaCell’s Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents by GlobeNewsWire
- Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk by GlobeNewsWire
- Lassonde Industries Inc. announces departure of Eric Gemme, Chief Financial Officer, in July 2026 by GlobeNewsWire
- Cerence AI Brings State-of-the-Art Voice Interaction to LG TVs with Human-Like Neural Text-to-Speech by GlobeNewsWire
- Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025 by GlobeNewsWire
- Park National Corporation names Matthew R. Miller Chief Executive Officer; David L. Trautman to continue as Board Chair by GlobeNewsWire
- Captivision, Inc. Announces Extension Granted by Nasdaq to Regain Compliance with Periodic Filing Requirement by GlobeNewsWire
- UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025 by GlobeNewsWire
- Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th by GlobeNewsWire
- Mercurity Fintech Announces Registered Direct Offering Was Not Consummated by GlobeNewsWire
- Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma by GlobeNewsWire